Clinical trial
Clinical Investigation Plan (CIP) for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
NCT01600482 is registered in ClinicalTrials.gov with Vasorum Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation Plan (CIP) for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
- Lead sponsor
- Vasorum Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- February 29, 2016
- Enrollment
- 241 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac disease, coronary artery disease